These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8435920)

  • 1. Immunosuppressive agents in dermatology.
    Ho VC; Zloty DM
    Dermatol Clin; 1993 Jan; 11(1):73-85. PubMed ID: 8435920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive agents in dermatology. An update.
    Dutz JP; Ho VC
    Dermatol Clin; 1998 Apr; 16(2):235-51. PubMed ID: 9589197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid.
    Mabrouk D; Gürcan HM; Keskin DB; Christen WG; Ahmed AR
    Ann Pharmacother; 2010 Nov; 44(11):1770-6. PubMed ID: 20923942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medicamental immunosuppression in dermatology (author's transl)].
    Goerz G; Merk H
    Z Hautkr; 1981 Aug; 56(15):975-90. PubMed ID: 7269720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic ciclosporin and tacrolimus in dermatology.
    Madan V; Griffiths CE
    Dermatol Ther; 2007; 20(4):239-50. PubMed ID: 17970889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases].
    Schulze P
    Z Arztl Fortbild (Jena); 1977 Jun; 71(12):562-4. PubMed ID: 20701
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines for prescribing azathioprine in dermatology.
    Anstey AV; Wakelin S; Reynolds NJ;
    Br J Dermatol; 2004 Dec; 151(6):1123-32. PubMed ID: 15606506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the use of ciclosporin in immune-mediated dermatoses.
    Griffiths CE; Katsambas A; Dijkmans BA; Finlay AY; Ho VC; Johnston A; Luger TA; Mrowietz U; Thestrup-Pedersen K
    Br J Dermatol; 2006 Jul; 155 Suppl 2():1-16. PubMed ID: 16774579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of cyclosporine in dermatology.
    Dehesa L; Abuchar A; Nuno-Gonzalez A; Vitiello M; Kerdel FA
    J Drugs Dermatol; 2012 Aug; 11(8):979-87. PubMed ID: 22859244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review and update of the clinical uses of cyclosporine in dermatology.
    Groisser DS; Griffiths CE; Ellis CN; Voorhees JJ
    Dermatol Clin; 1991 Oct; 9(4):805-17. PubMed ID: 1934654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
    Sandborn WJ
    Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta).
    Matalon ST; Ornoy A; Lishner M
    Reprod Toxicol; 2004; 18(2):219-30. PubMed ID: 15019720
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in immunosuppressive therapy.
    Marder W; McCune WJ
    Semin Respir Crit Care Med; 2007 Aug; 28(4):398-417. PubMed ID: 17764058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of systemic immune moderators in dermatology: an update.
    Kazlow Stern D; Tripp JM; Ho VC; Lebwohl M
    Dermatol Clin; 2005 Apr; 23(2):259-300. PubMed ID: 15837155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
    Bernatsky S; Joseph L; Boivin JF; Gordon C; Urowitz M; Gladman D; Fortin PR; Ginzler E; Bae SC; Barr S; Edworthy S; Isenberg D; Rahman A; Petri M; Alarcón GS; Aranow C; Dooley MA; Rajan R; Sénécal JL; Zummer M; Manzi S; Ramsey-Goldman R; Clarke AE
    Ann Rheum Dis; 2008 Jan; 67(1):74-9. PubMed ID: 17545189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA; McCune WJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use.
    Behnam SM; Behnam SE; Koo JY
    J Drugs Dermatol; 2005; 4(2):189-94. PubMed ID: 15776776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive and cytotoxic drugs: uses in the dermatologic patient.
    Callen JP
    Adv Dermatol; 1990; 5():3-19; discussion 20. PubMed ID: 2204377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.